
Po-chih Chen
Examiner (ID: 15962, Phone: (571)270-7243 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1626 |
| Total Applications | 947 |
| Issued Applications | 619 |
| Pending Applications | 116 |
| Abandoned Applications | 237 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16839403
[patent_doc_number] => 20210147415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION
[patent_app_type] => utility
[patent_app_number] => 17/091247
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17091247
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/091247 | INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION | Nov 5, 2020 | Abandoned |
Array
(
[id] => 19674480
[patent_doc_number] => 12186318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Pharmaceutical composition for preventing or treating cancer comprising KSP inhibitor and mitosis inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/083895
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 38
[patent_no_of_words] => 12262
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083895 | Pharmaceutical composition for preventing or treating cancer comprising KSP inhibitor and mitosis inhibitor | Oct 28, 2020 | Issued |
Array
(
[id] => 16688291
[patent_doc_number] => 20210070767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/082650
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17082650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/082650 | Apelin receptor (APJ) agonists and uses thereof | Oct 27, 2020 | Issued |
Array
(
[id] => 16791608
[patent_doc_number] => 20210121425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/080523
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17080523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/080523 | ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS | Oct 25, 2020 | Abandoned |
Array
(
[id] => 16776480
[patent_doc_number] => 20210113557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHODS OF TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/075808
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075808 | METHODS OF TREATING PROSTATE CANCER | Oct 20, 2020 | Abandoned |
Array
(
[id] => 16711822
[patent_doc_number] => 20210078969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => Nrf2 Activating Compounds and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/075152
[patent_app_country] => US
[patent_app_date] => 2020-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/075152 | Nrf2 activating compounds and uses thereof | Oct 19, 2020 | Issued |
Array
(
[id] => 17875460
[patent_doc_number] => 11447461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Benzothiophene-based selective estrogen receptor downregulators
[patent_app_type] => utility
[patent_app_number] => 17/074550
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 25316
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17074550
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/074550 | Benzothiophene-based selective estrogen receptor downregulators | Oct 18, 2020 | Issued |
Array
(
[id] => 19777390
[patent_doc_number] => 12226410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6
[patent_app_type] => utility
[patent_app_number] => 17/073603
[patent_app_country] => US
[patent_app_date] => 2020-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 123
[patent_figures_cnt] => 123
[patent_no_of_words] => 22575
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17073603
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/073603 | Methods for enhancing cellular clearance of pathological molecules via activation of the cellular protein ykt6 | Oct 18, 2020 | Issued |
Array
(
[id] => 16807794
[patent_doc_number] => 20210130347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/071056
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/071056 | Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases | Oct 14, 2020 | Issued |
Array
(
[id] => 16976116
[patent_doc_number] => 20210220353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => USE OF FAVIPIRAVIR IN TREATMENT OF CORONAVIRUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/070620
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070620 | USE OF FAVIPIRAVIR IN TREATMENT OF CORONAVIRUS INFECTION | Oct 13, 2020 | Abandoned |
Array
(
[id] => 16765771
[patent_doc_number] => 20210111353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/065816
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 345
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065816 | Compound and photoelectric device, image sensor, and electronic device including the same | Oct 7, 2020 | Issued |
Array
(
[id] => 16596583
[patent_doc_number] => 20210023114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/064267
[patent_app_country] => US
[patent_app_date] => 2020-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064267 | Compositions and methods for treating an infection | Oct 5, 2020 | Issued |
Array
(
[id] => 17111692
[patent_doc_number] => 20210292289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => HETEROCYCLIC GLUTAMINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/063066
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063066 | HETEROCYCLIC GLUTAMINASE INHIBITORS | Oct 4, 2020 | Abandoned |
Array
(
[id] => 17913184
[patent_doc_number] => 20220315579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PYRIDONE COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/033475
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17033475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/033475 | Pyridone compounds and methods of use | Sep 24, 2020 | Issued |
Array
(
[id] => 16748771
[patent_doc_number] => 20210100780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => METHODS FOR TREATING WILD TYPE ISOCITRATE DEHYDROGENASE 1 CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/030844
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/030844 | Methods for treating wild type isocitrate dehydrogenase 1 cancers | Sep 23, 2020 | Issued |
Array
(
[id] => 18018964
[patent_doc_number] => 20220370463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSION
[patent_app_type] => utility
[patent_app_number] => 17/761027
[patent_app_country] => US
[patent_app_date] => 2020-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761027 | STABILIZED C-FMS INTRACELLULAR FRAGMENTS (FICD) PROMOTE OSTEOCLAST DIFFERENTIATION AND ARTHRITIC BONE EROSION | Sep 17, 2020 | Pending |
Array
(
[id] => 17913183
[patent_doc_number] => 20220315578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/020114
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020114 | BRD9 BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE | Sep 13, 2020 | Pending |
Array
(
[id] => 18567008
[patent_doc_number] => 20230257337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHOD FOR PRODUCING POLYGYLCEROL ESTERS OF POLYCARBOXYLIC ACIDS ESTERIFIED WITH OXOBUTANOL
[patent_app_type] => utility
[patent_app_number] => 18/004753
[patent_app_country] => US
[patent_app_date] => 2020-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004753
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004753 | METHOD FOR PRODUCING POLYGYLCEROL ESTERS OF POLYCARBOXYLIC ACIDS ESTERIFIED WITH OXOBUTANOL | Sep 6, 2020 | Pending |
Array
(
[id] => 17896992
[patent_doc_number] => 20220306654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => MECHANOREDOX REACTION USING PIEZOELECTRIC MATERIAL, AND PRODUCTION METHOD USING SAID REACTION
[patent_app_type] => utility
[patent_app_number] => 17/640135
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17640135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/640135 | MECHANOREDOX REACTION USING PIEZOELECTRIC MATERIAL, AND PRODUCTION METHOD USING SAID REACTION | Sep 3, 2020 | Abandoned |
Array
(
[id] => 16613603
[patent_doc_number] => 20210032256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/010089
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 1064
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010089 | 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives | Sep 1, 2020 | Abandoned |